These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6367055)

  • 41. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update.
    Sanders JE; Thomas ED; Buckner CD; Flournoy N; Stewart PS; Clift RA; Lum L; Bensinger WI; Storb R; Appelbaum FR
    Blood; 1985 Aug; 66(2):460-2. PubMed ID: 3893570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [High-dose cyclophosphamide and whole-body radiotherapy followed by bone marrow transplant in patients with leukemia].
    Fernández-Rañada JM; Vázquez L; Lozano M; Fernández-Garese D; Figuera A; Arranz R; González N; Gómez N; Fernández Villalta MJ; Gómez-Reino F
    Rev Clin Esp; 1987 Mar; 180(5):247-52. PubMed ID: 3299537
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute lymphoblastic and nonlymphoblastic leukemia in 1st complete remission: consolidation treatment by intensive radio-chemotherapy followed by transplantation of HLA-A, B and Dr compatible allogeneic bone marrow].
    Gyger M; Perreault C; Bonny Y; Bélanger R; David M; Boileau J; Tawil E; Lavallée R; Lacombe M; d'Angelo G
    Union Med Can; 1986 Oct; 115(10):699-702. PubMed ID: 3541340
    [No Abstract]   [Full Text] [Related]  

  • 44. Current developments in marrow transplantation.
    O'Reilly RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):92-102. PubMed ID: 3547846
    [No Abstract]   [Full Text] [Related]  

  • 45. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.
    Tutschka PJ; Copelan EA; Kapoor N
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2952-4. PubMed ID: 2650402
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
    Tutschka PJ
    Bone Marrow Transplant; 1993; 12 Suppl 1():34-6. PubMed ID: 8374557
    [No Abstract]   [Full Text] [Related]  

  • 48. Cutaneous busulfan effect in patients receiving bone-marrow transplantation.
    Hymes SR; Simonton SC; Farmer ER; Beschorner WB; Tutschka PJ; Santos GW
    J Cutan Pathol; 1985 Apr; 12(2):125-9. PubMed ID: 3889081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
    Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
    Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
    Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
    [No Abstract]   [Full Text] [Related]  

  • 51. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
    Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
    Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation.
    Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A
    Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of various conditioning regimens on the outcome of bone marrow transplantation for leukemia.
    Devergie A; Socie G; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
    Nouv Rev Fr Hematol (1978); 1991; 33(6):437-9. PubMed ID: 1818295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
    Forman SJ; Blume KG; Krance RA; Miner PJ; Metter GE; Hill LR; O'Donnell MR; Nademanee AP; Snyder DS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2605-7. PubMed ID: 3079090
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
    Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y
    Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.
    Rizzoli V; Carella AM; Carlo-Stella C; Mangoni L
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():76-8. PubMed ID: 2202474
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
    Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: a preliminary report.
    Weiner RS; Dicke KA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2639-42. PubMed ID: 3029921
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination prophylactic immunosuppression in bone marrow transplantation.
    Szer J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3011-2. PubMed ID: 2650415
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone marrow transplantation--the Marsden experience.
    Helenglass G; Lakhani A; Powles R; Nandi A; Zuiable A; Gore M; Forgeson G; Treleaven J; Milliken S; Millar J
    Hematol Oncol; 1987; 5(4):245-54. PubMed ID: 3319865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.